This site contains affiliate links. We may earn a commission when you click — at no extra cost to you. Learn more
The Consultation

What Happens During a GLP-1 Telehealth Consultation?

You've decided to explore GLP-1 treatment through a telehealth provider. You've picked a platform. You're staring at a "Get Started" button. But what actually happens when you click it?

Every telehealth platform handles the consultation differently, but the core process follows a predictable structure. Here's what to expect at each stage — and how to tell if the process you're going through meets a reasonable clinical standard.

Stage 1: The Intake Questionnaire (5–15 Minutes)

Before you speak to anyone, you'll fill out a health questionnaire. This is the digital equivalent of the clipboard forms at a doctor's office, and it's more important than it looks — this information drives the clinical decision.

A thorough intake should ask about:

🚩 Red Flag

If the intake questionnaire only asks your height, weight, and payment information — with no medical history screening — that's a serious red flag. A legitimate clinical process requires comprehensive health information before prescribing.

Stage 2: Provider Review (Asynchronous) or Live Consultation

This is where telehealth platforms diverge significantly:

Asynchronous Review (Most Common)

The majority of GLP-1 telehealth platforms use an asynchronous model. Your intake questionnaire is reviewed by a licensed provider — typically a physician (MD/DO) or nurse practitioner (NP) — who evaluates your information without a live video call. You may exchange messages through the platform's portal.

This model is faster (often same-day or next-day decisions) and usually less expensive. The trade-off: you don't get the back-and-forth of a live conversation. If you have complex medical history or specific questions, an async review may feel insufficient.

Video Consultation (Less Common, Higher Touch)

Some platforms offer live video visits, typically lasting 10–20 minutes. This gives you face time with your provider, the ability to ask questions in real time, and a more traditional clinical experience. These appointments often need to be scheduled days in advance and may cost more.

Neither model is inherently better. What matters is whether the provider has enough information to make a safe prescribing decision and whether you have a channel to ask questions before your medication arrives.

Stage 3: The Clinical Decision

Based on your intake, the provider will make one of several decisions:

Turnaround time varies: some platforms make decisions within hours; others take 2–3 business days. If you haven't heard back within a week, follow up.

Stage 4: Pharmacy Fulfillment

Once your prescription is written, it's sent to a pharmacy — either a retail pharmacy (for brand-name medications) or a compounding pharmacy (for compounded formulations). Here's what happens next:

Embody

Injectable semaglutide with physician oversight

$149 first month, $299/mo after

Start Your Consultation →

Paid link · Compounded medications are not FDA-approved and are prepared by licensed pharmacies.

Stage 5: Onboarding and Your First Dose

Quality platforms don't just ship medication and disappear. After you receive your prescription, you should get:

Stage 6: Follow-Up (The Part Most People Forget)

Your initial consultation is just the beginning. GLP-1 therapy requires ongoing clinical oversight:

If your provider has no follow-up process — if it's "here's your medication, see you in six months" — that's a clinical quality concern. The titration phase especially requires active medical oversight.

Compare Telehealth Providers

Embody $149 first month, $299/mo after
Get Started →
GobyMeds $99/mo semaglutide bundle
Get Started →
Gala GLP-1 $179/mo flat rate
Get Started →
Care Bare Rx From $199/mo
Get Started →

Paid links · Compounded medications are not FDA-approved.

How to Judge the Quality of Your Experience

After going through the process, ask yourself these questions:

The bar for telehealth GLP-1 prescribing should be just as high as in-person prescribing. Convenience shouldn't come at the cost of clinical thoroughness.